Poolbeg Pharma PLC Hisse Grafiği

Poolbeg Pharma Plc is a clinical-stage biopharmaceutical company, which focuses on the development of innovative medicines to address unmet medical needs. The firm's capital light clinical model enables to develop multiple products faster than the traditional biotech model. Its portfolio includes POLB 001, Phase II ready, repositioned small molecule immunomodulatory for severe influenza, along with a vaccine discovery platform, PredictViral biomarker platform, and the disease progression data & bio banks that will be interrogated using AI platforms. The company was founded on March 19, 2021 and is headquartered in London, the United Kingdom.